Enrollment of first patient in melanoma phase II clinical trial for Telomelysin® (OBP-301) in the US read more
The First EV71 Vaccine Protecting 2 ~6 Months Old Babies Wins Taiwan’s National Innovation Award read more
TBG Diagnostics and Omixon formalise Asia Pacific partnership for Holotype HLA Typing product distribution read more
Medigen’s Liver Cancer New Drug OBP-301 has signed License Agreement with Jiangsu Hengrui Medicine read more
Medigen Vaccine Biologics (MVC)’s Inaugurates Taiwan’s First Cell-Based Vaccine Manufacturing Plant read more